Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Jun 20 2026
Oct 12 2025
Mar 7 2026
May 30 2026
Feb 19 2026